NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Lyka Labs Limited (NSE: LYKALABS)

LYKALABS Technical Analysis
As on 25th Nov 2022 LYKALABS SHARE Price closed @ 136.25 and we RECOMMEND Sell for LONG-TERM with Stoploss of 136.75 & Buy for SHORT-TERM with Stoploss of 133.08 we also expect STOCK to react on Following IMPORTANT LEVELS.


Open 128.00 Change Price %
High 138.65 1 Day 8.85 6.95
Low 126.85 1 Week 11.75 9.44
Close 136.25 1 Month 8.20 6.40
Volume 312562 1 Year -5.50 -3.88
52 Week High 254.30 | 52 Week Low 10.45
NSE INDIA Most Active Stocks
PNB 53.60 5.41%
SUZLON 8.45 6.96%
IRFC 31.80 2.91%
BHEL 81.95 9.56%
YESBANK 16.95 0.00%
SOUTHBANK 16.15 8.39%
UCOBANK 20.75 1.47%
EXCEL 0.30 20.00%
IDEA 8.05 0.00%
RVNL 73.30 9.16%
NSE INDIA Top Gainers Stocks
EXCEL 0.30 20.00%
ITDC 404.55 19.99%
PEARLPOLY 20.95 18.70%
PANAMAPET 406.30 14.34%
IBULHSGFIN 138.15 11.64%
NATHBIOGEN 160.10 11.41%
TREJHARA 80.45 11.20%
UMESLTD 5.10 9.68%
BHEL 81.95 9.56%
BSL 224.95 9.54%
NSE INDIA Top Losers Stocks
MAHSEAMLES 387.25 -50.26%
DUCON 11.05 -11.60%
WELINV 321.00 -8.30%
INDBANK 27.90 -6.69%
ANTGRAPHIC 0.75 -6.25%
UGROCAP 153.55 -6.14%
SCAPDVR 14.40 -4.95%
WIPL 100.60 -4.91%
ANSALAPI 18.55 -4.87%
ABMINTLLTD 66.60 -4.79%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
LYKALABS Important Levels Intraday
LYKALABS Target November 2022
4th UP Target222.36
3rd UP Target191.09
2nd UP Target171.76
1st UP Target152.43
1st DOWN Target97.27
2nd DOWN Target77.94
3rd DOWN Target58.61
4th DOWN Target27.34
LYKALABS Weekly Target
4th UP Target166.51
3rd UP Target153.04
2nd UP Target144.71
1st UP Target136.38
1st DOWN Target112.62
2nd DOWN Target104.29
3rd DOWN Target95.96
4th DOWN Target82.49
LYKALABS Target2022
4th UP Target718.31
3rd UP Target559.24
2nd UP Target460.91
1st UP Target362.58
1st DOWN Target82.02
2nd DOWN Target-16.31
3rd DOWN Target-114.64
4th DOWN Target-273.71
LYKALABS Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is 22.98 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 16.18
10 Day Avg Volume Traded 247.61 % More then 10 Day Average Volume
LYKALABS Other Details
Segment EQ
Market Capital 2685383936.00
Sector Healthcare
Industry Biotechnology
Offical website >
LYKALABS Latest News
Your Comments and Response on Lyka Labs Limited
LYKALABS Business Profile
Lyka Labs Limited engages in the manufacturing and sale of pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. It manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, muscle relaxant, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. The company also provides contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, BA/BE clinical study data, etc. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia, as well as deals in pharmaceutical products. Lyka Labs Limited offers its products in various formulations, including injections, creams, ointments, foams, gels, and lotions. Further, the company exports its products to Bangladesh, Combodia, Congo, Costa Rica, Peru, Romania, Russia, Sri Lanka, Sudan, Ukraine, Venezuela, and Vietnam. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India. Address: Spencer Building, Mumbai, India, 400036
2005-2021 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service